Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Puma Biotechnology Inc (0PB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Puma Biotech historical data, for real-time data please try another search
6.0800 0.0000    0.00%
18/08 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US74587V1070 
S/N:  A1J643
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 6.0800 - 6.0800
Puma Biotech 6.0800 0.0000 0.00%

NASDAQ:0PB Financials

 
A brief overview of the NASDAQ:PBYI financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Puma Biotechnology Inc over time.

Puma Biotechnology, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 235.64 million compared to USD 228.03 million a year ago. Net income was USD 21.59 million compared to USD 0.002 million a year ago. Basic earnings per share from continuing operations was USD 0.46. Diluted earnings per share from continuing operations was USD 0.45.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

0PB Income Statement

Gross margin TTM 73.4%
Operating margin TTM 14.12%
Net Profit margin TTM 9.16%
Return on Investment TTM 19.02%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 72.18 56.12 54.57 52.78
Gross Profit 47.86 42.83 42.71 39.56
Operating Income 15.42 8.58 4.89 4.36
Net Income 12.27 5.8 2.13 1.4

0PB Balance Sheet

Quick Ratio MRQ 1.45
Current Ratio MRQ 1.57
LT Debt to Equity MRQ 122.86%
Total Debt to Equity MRQ 208.62%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 230.53 203.6 200.49 196.26
Total Liabilities 177.09 164.86 170.1 170.41
Total Equity 53.44 38.74 30.4 25.85

0PB Cash Flow Statement

Cash Flow/Share TTM 0.57
Revenue/Share TTM 4.95
Operating Cash Flow  10.53%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 10.46 10.62 3.3 2.64
Cash From Investing Activities -8.17 11.18 -4.68 -17.45
Cash From Financing Activities
Net Change in Cash 2.28 21.79 -1.39 -14.81
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PBYI Comments

Write your thoughts about Puma Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Mahony
Mike Mahony Dec 23, 2022 4:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bad Article from financial advisor on seeking alpha...that the ones who let fill stop loss hunting orders
Seller Beware
Seller Beware Dec 13, 2021 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just look at this stpd chart. How crazy rich are these Puma Sellers. They only laugh at poor Puma
Seller Beware
Seller Beware Dec 13, 2021 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pump* Biotech
Jimmy Barjami
Jimmy Barjami Nov 17, 2021 7:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s going on with this toxic stock
Episcopolian OptionTrader
Episcopolian1 May 07, 2020 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Puma Biotechnology Q1 Adj. EPS $(0.200) Beats $(0.730) Estimate, Sales $48.600M Beat $47.060M Estimate
Peter Wiedeking
Peter Wiedeking Feb 05, 2020 1:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14,5 short
Anthony Santos
Anthony Santos Nov 06, 2019 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today will be earnings as All eyes will be on the Useless CEO
Episcopolian OptionTrader
Episcopolian1 Jul 12, 2017 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leerink set PT to $115. Wonder if they think there is no immediate buyer?
Episcopolian OptionTrader
Episcopolian1 May 23, 2017 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PBYI will be presenting at ASCO on 6/3/17. Buy the stock now... This can go above $100 easily before the event
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email